The Canadian HIV Cure Enterprise (CanCURE) is a research collaborative focused on studying HIV persistence during antiretroviral therapy and developing strategies towards a sustainable HIV remission. Our innovative scientific program is supported by the Canadian Institutes of Health Research (CIHR).
With partnership and engagement as some of the policy directions guiding the Federal Initiative to Address HIV/AIDS in Canada, CanCURE is committed to CIHR principles of Citizen Engagement and community involvement in conducting its research program.
Citizens are “engaged” when they play an active role in defining issues, considering solutions, and identifying resources or priorities for action. This “meaningful involvement” can take place at a variety of stages in the research, planning, or implementation phases of a project.
In the case of HIV Cure research, this means putting mechanisms into effect that ensure the greater involvement and meaningful engagement of people living with HIV/AIDS (GIPA/MIPA); GIPA/MIPA is a principle that puts people living with HIV/AIDS at the centre, while being grounded in human rights as well as the dignity of the full human being.
CanCURE has established a Community Advisory Board with representatives from across Canada. These dedicated individuals provide the perspective of the community in our internal review and decision‐making process throughout the duration of the CanCURE program.
CanCURE is currently seeking nominations from community members to fill several positions on this advisory board. CanCURE strives to be representative of Canada’s geographic regions as well as Canadian populations most affected by HIV and related health conditions.
In order to maintain this balance, the CanCURE Community Advisory Board is seeking nominations that reflect the diversity of affected population groups from all parts of Canada. Potential advisory board members should have:
• A knowledge of or interest in HIV cure research
• Demonstrated connection to the community of people living with HIV
• An understanding of issues of importance to various HIV communities
• Proficiency in spoken and written English. Francophones are encouraged to apply.
A scientific background is not required, and training materials are provided.
Interested individuals should forward a letter of interest and a brief resumé by Monday, June 27, 2022 to: CanCURE Community Advisory Board Co‐Chairs Ron Rosenes and Shari Margolese via Angela Durant [email protected]